The binding of CXC-motif chemokine receptor 2 (CXCR2) by its ligand CXCL2 provides an alternative signaling pathway to induce angiogenesis in gliomas via activation of immune host cells and independently of VEGF signaling [60]. Here, CXCR2 is linked to central nervous system cancer.